Results 171 to 180 of about 452,519 (325)

Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths

Annals of Neurology, EarlyView.
Objective Though it is widely known that tau deposition affects brain structure, the precise localization of these effects is poorly understood, especially in relation to gyral and sulcal anatomy. We investigated whether tau pathology in Alzheimer's disease (AD) preferentially affects sulci, and particularly sulcal depths.
Samira A. Maboudian, Corrina S. Fonseca, Adam C. Martersteck, Yishu Chao, Yuheng Chen, Daniela Ushizima, Duygu Tosun, Lea T. Grinberg, Kevin S. Weiner, William J. Jagust, for the Alzheimer's Disease Neuroimaging Initiative   +10 more
wiley   +1 more source

Synthesis and application of (18F) fluorodeoxyglucose in oncology diagnosis

Journal of Education, Health and Sport, 2017
[18F] Fluorodeoxyglucose ([18F] FDG) is the most commonly used radiopharmaceutical in clinical positron emission tomography (PET) in oncology. Cancer cells create their own specific microenvironment to survive and grow.
Mateusz Wędrowski, Paweł Waśniowski, Ewelina Wędrowska, Elżbieta Piskorska, Jolanta Czuczejko, Bogdan Małkowski, Walery Żukow   +6 more
doaj  

A System for Cerebral Blood Flow Measurement Using an H₂¹⁵O Autoradiographic Method and Positron Emission Tomography [PDF]

, 1987
Iwao Kanno, Hidehiro Iida, Shuichi Miura, M.T. Murakami, Kazuhiro Takahashi, Hiroshi Sasaki, A Inugami, F Shishido, Kazuki Uemura   +8 more
openalex   +1 more source

Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling

Annals of Neurology, EarlyView.
Objective Age of symptom onset is highly variable in familial frontotemporal lobar degeneration (f‐FTLD). Accurate prediction of onset would inform clinical management and trial enrollment. Prior studies indicate that individualized maps of brain atrophy can predict conversion to dementia in f‐FTLD.
Shubir Dutt, Dana Leichter, Yann Cobigo, Amy Wolf, John Kornak, Annie Clark, Lucy L. Russell, Arabella Bouzigues, David M. Cash, Martina Bocchetta, Molly Olzinski, Brian Appleby, Ece Bayram, Barbara Borroni, Andrea Bozoki, Chris R. Butler, David Clark, Rhian S. Convery, R. Ryan Darby, Alexandre de Mendonça, Bradford Dickerson, Kimiko Domoto‐Reilly, Simon Ducharme, Eve Ferry‐Bolder, Elizabeth Finger, Phoebe H. Foster, Douglas R. Galasko, Daniela Galimberti, Alexander Gerhard, Nupur Ghoshal, Caroline Graff, Neill Graff‐Radford, Ian M. Grant, Chadwick M. Hales, Lawrence S. Honig, Ging‐Yuek Hsiung, Edward D. Huey, David Irwin, Lize C. Jiskoot, Walter Kremers, Justin Y. Kwan, Robert Laforce, Isabelle Le Ber, Gabriel C. Léger, Johannes Levin, Irene Litvan, Ian R. Mackenzie, Mario Masellis, Mario F. Mendez, Fermin Moreno, Chiadi Onyike, Markus Otto, Belen Pascual, Peter Pressman, Rosa Rademakers, Eliana Marisa Ramos, Aaron Ritter, Erik D. Roberson, James B. Rowe, Raquel Sanchez‐Valle, Isabel Santana, Harro Seelaar, Allison Snyder, Sandro Sorbi, Matthis Synofzik, Maria Carmela Tartaglia, Pietro Tiraboschi, John C. van Swieten, Marijne Vandebergh, Rik Vandenberghe, Hilary W. Heuer, Bruce L. Miller, William W. Seeley, Maria Luisa Gorno‐Tempini, Joel H. Kramer, Leah Forsberg, Kejal Kantarci, Bradley F. Boeve, Adam L. Boxer, Jonathan D. Rohrer, Howard J. Rosen, Adam M. Staffaroni, FTD Prevention Initiative (FPI) investigators   +82 more
wiley   +1 more source

Characterizing amyloid and tau positron emission tomography-based stages across the clinical continuum. [PDF]

Alzheimers Dement
Cody KA, Sokołowski A, Johns E, Guerra LM, Winer JR, Young CB, Younes K, Dumitrescu L, Archer DB, Durant A, Sathe A, Koran MEI, Mez J, Saykin AJ, Toga A, Cuccaro M, Tosun D, Insel PS, Johnson SC, Harrison TM, Hohman TJ, Mormino EC.   +21 more
europepmc   +1 more source

Positron Emission Tomography /Computed Tomography Follow-Up in Patients with Gastrointestinal Tract Malignancies

, 2020
Abdellatief Mohammed Khairy Eltahan, Mohamad Abd El-Hamid Alm El- Din, Alsiagy Ali Abdel- Aziz, Emad M. Mashaly   +3 more
openalex   +2 more sources

Advances in positron emission tomography technology have increased the need for surgical staging in non–small cell lung cancer [PDF]

, 2007
Benjamin Enoch Lee, Derek von Haag, Teri Lown, Derick Lau, Royce Calhoun, David M. Follette   +5 more
openalex   +1 more source

Dual Modality Semiconducting Polymer Nanoparticles for Use in Optical and Magnetic Resonance Imaging

Advanced NanoBiomed Research, EarlyView.
Well‐defined dual‐modality semiconducting polymer nanoparticles composed of red‐emitting conjugated polymers functionalized with novel gadolinium‐based contrast agents have been prepared. The assemblies show a greatly enhanced relaxivity performance compared to the clinical standard, Dotarem, while offering ultrabright fluorescence, ideal for optical ...
Faysal A. Farah, Yu Qin, Xin Shi, Dylan M. Owen, Mark A. Green, James D. E. T. Wilton‐Ely   +5 more
wiley   +1 more source

Positron emission tomography scan for predicting clinical outcome of patients with recurrent cervical carcinoma following radiation therapy

, 2012
DayaNand Sharma, GouraKisor Rath, Rakesh Kumar, Arun Malhotra, Sunesh Kumar, Pandjatcharam Jagadesan, Sagar Maharjan   +6 more
openalex   +1 more source

The clinical stage of non–small cell lung cancer as assessed by means of fluorodeoxyglucose–positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers [PDF]

, 2006
Ayesha S. Bryant, Robert J. Cerfolio
openalex   +1 more source